Rezultati - Csenger Kovácsházi
- Showing 1 - 3 results of 3
-
1
Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents od Ádám Póti, Hella Gyergyák, Eszter Németh, Orsolya Rusz, Szilárd Tóth, Csenger Kovácsházi, Dan Chen, Bernadett Szikriszt, Sándor Spisák, Shunichi Takeda, Gergely Szakács, Zoltán Szállási, Andrea L. Richardson, Dávid Szüts
Izdano 2019Artigo -
2
Circulating cardiomyocyte-derived extracellular vesicles reflect cardiac injury during systemic inflammatory response syndrome in mice od Hargita Hegyesi, Éva Pállinger, Szabina Mecsei, Balázs Hornyák, Csenger Kovácsházi, Gábor B. Brenner, Zoltán Giricz, Krisztina Pálóczi, Ágnes Kittel, József Tóvári, Lilla Turiák, Delaram Khamari, Péter Ferdinandy, Edit I. Buzás
Izdano 2022Artigo -
3
Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2 od Sha Chen, Qian Wang, Diane Bakker, Xin Hu, Liping Zhang, Ingeborg van der Made, Anna M. Tebbens, Csenger Kovácsházi, Zoltán Giricz, Gábor B. Brenner, Péter Ferdinandy, Gert Schaart, Anne Gemmink, Matthijs K. C. Hesselink, Mathilde R. Rivaud, Michael Pieper, Markus W. Hollmann, Nina C. Weber, Jean‐Luc Balligand, Esther E. Creemers, Ruben Coronel, Coert J. Zuurbier
Izdano 2024Artigo
Iskalna orodja:
Sorodne teme
Biology
Chemistry
Internal medicine
Medicine
Cardiomyopathy
Cell biology
DNA mismatch repair
DNA repair
Diabetes mellitus
Diabetic cardiomyopathy
EMPA
Electron microprobe
Empagliflozin
Endocrinology
Extracellular
Extracellular vesicles
Gene
Genetics
Heart failure
Homologous recombination
Immunology
Inflammation
Inflammatory response
Mineralogy
Mutation
Nitric oxide
Pharmacology
RAD51
Sepsis
Systemic inflammation